campesterol has been researched along with Diabetes Mellitus, Adult-Onset in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 4 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Arasaki, O; Chihara, A; Morimoto, T; Node, K; Nomiyama, T; Sakuma, M; Shimabukuro, M; Tanaka, A; Ueda, S | 1 |
| Biddinger, SB; Bullock, K; Clish, CB; de Ferranti, SD; Dolan, LM; Khoury, PR; Kimball, TR; Krawczyk, J; Levenson, AE; Maahs, DM; Semova, I; Shah, AS; Urbina, EM; Wadwa, RP; Williams, KA | 1 |
| Aso, Y; Iijima, T; Jojima, T; Kogai, T; Saito, M; Sakurai, S; Tomaru, T; Usui, I; Wakamatsu, S | 1 |
| Doumas, M; Papadopoulos, C; Patoulias, D | 1 |
| Jojima, T | 1 |
| Aoki, K; Ijima, T; Kamiko, K; Kamiyama, H; Terauchi, Y | 1 |
| Chan, DC; Ng, TW; Ooi, EM; Watts, GF | 1 |
| Ishibashi, S; Kotani, K; Miyamoto, M; Nagasaka, S; Okada, K; Osuga, J; Yagyu, H | 1 |
| Ceglarek, U; Farmer, A; Holman, RR; Neil, HA; Paul, S; Thiery, J | 1 |
| Athias, A; Beacco, M; Bouillet, B; Brindisi, MC; Cercueil, JP; Duvillard, L; Guiu, B; Hillon, P; Petit, JM; Rollot, F; Verges, B | 1 |
| Gylling, H; Miettinen, TA | 1 |
| Cox, C; Lintott, CJ; Robertson, MC; Scott, RS; Stapely, SA; Sutherland, WH | 1 |
5 trial(s) available for campesterol and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Differences in lipid metabolism between anagliptin and sitagliptin in patients with type 2 diabetes on statin therapy: a secondary analysis of the REASON trial.
Topics: Aged; Biomarkers; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Dyslipidemias; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Japan; Male; Middle Aged; Phytosterols; Pyrimidines; Sitagliptin Phosphate; Sitosterols; Time Factors; Treatment Outcome | 2019 |
Empagliflozin increases plasma levels of campesterol, a marker of cholesterol absorption, in patients with type 2 diabetes: Association with a slight increase in high-density lipoprotein cholesterol.
Topics: Benzhydryl Compounds; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Glucosides; Humans; Phytosterols | 2021 |
Anagliptin decreases serum lathosterol level in patients with type 2 diabetes: a pilot study.
Topics: Adult; Aged; Biomarkers; Cholestanol; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Lipids; Lipoproteins, HDL; Male; Middle Aged; Phytosterols; Pilot Projects; Pyrimidines; Sitosterols; Young Adult | 2015 |
Lipid-lowering effects of ezetimibe for hypercholesterolemic patients with and without type 2 diabetes mellitus.
Topics: Aged; Azetidines; Biomarkers; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholestanol; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Type 2; Ezetimibe; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipids; Male; Middle Aged; Phytosterols; Sitosterols | 2010 |
Impact of atorvastatin and omega-3 ethyl esters 90 on plasma plant sterol concentrations and cholesterol synthesis in type 2 diabetes: a randomised placebo controlled factorial trial.
Topics: Anticholesteremic Agents; Atorvastatin; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Type 2; Docosahexaenoic Acids; Double-Blind Method; Drug Combinations; Eicosapentaenoic Acid; Heptanoic Acids; Humans; Lanosterol; Phytosterols; Pyrroles; Triglycerides | 2010 |
7 other study(ies) available for campesterol and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Markers of cholesterol synthesis are elevated in adolescents and young adults with type 2 diabetes.
Topics: Adolescent; Adult; Biomarkers; Body Mass Index; Case-Control Studies; Cholesterol; Diabetes Mellitus, Type 2; Humans; Obesity; Phytosterols; Sitosterols; Young Adult | 2020 |
Effect of empagliflozin on cholesterol synthesis and absorption markers in patients with type 2 diabetes: Any role of DPP-4 inhibitors?
Topics: Benzhydryl Compounds; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Glucosides; Humans; Phytosterols | 2021 |
Expectations for synergistically favorable effects of the combination therapy with DPP-4 inhibitor and SGLT2 inhibitor on cholesterol synthesis and absorption.
Topics: Benzhydryl Compounds; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Glucosides; Humans; Motivation; Phytosterols; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
Plasma markers of cholesterol homeostasis in metabolic syndrome subjects with or without type-2 diabetes.
Topics: Adiponectin; Apolipoprotein A-I; Apolipoproteins; Biomarkers; Blood Glucose; Blood Pressure; Cholesterol; Diabetes Mellitus, Type 2; Female; Gas Chromatography-Mass Spectrometry; Homeostasis; Humans; Male; Metabolic Syndrome; Middle Aged; Obesity; Phytosterols; Reference Values; Triglycerides | 2009 |
Liver fat content is associated with an increase in cholesterol synthesis independent of statin therapy use in patients with type 2 diabetes.
Topics: Aged; Biomarkers; Cholesterol; Diabetes Mellitus, Type 2; Dyslipidemias; Fatty Liver; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Linear Models; Liver; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multivariate Analysis; Non-alcoholic Fatty Liver Disease; Phytosterols; Risk Factors; Sitosterols; Treatment Outcome | 2012 |
Cholesterol absorption, synthesis, and LDL metabolism in NIDDM.
Topics: Absorption; Apolipoproteins B; Bile Acids and Salts; Cholesterol; Cholesterol, Dietary; Cholesterol, LDL; Diabetes Mellitus, Type 2; Dietary Fats; Humans; Hypercholesterolemia; Lipids; Male; Middle Aged; Phytosterols; Reference Values | 1997 |
Plasma non-cholesterol sterols in patients with non-insulin dependent diabetes mellitus.
Topics: Adult; Aged; Cholesterol; Diabetes Mellitus, Type 2; Female; Humans; Insulin; Male; Middle Aged; Phytosterols; Sitosterols | 1992 |